Disposable Syringes Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 15.77 Billion |
| Market Size (2029) | USD 24.86 Billion |
| CAGR (2024 - 2029) | 9.53 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Disposable Syringes Market Analysis
The Disposable Syringes Market size is estimated at USD 15.77 billion in 2024, and is expected to reach USD 24.86 billion by 2029, growing at a CAGR of 9.53% during the forecast period (2024-2029).
The disposable syringes market witnessed a significant growth disruption due to the COVID-19 pandemic. The heightened transmissibility of the SARS-CoV-2 virus led to a surge in disposable syringe usage. Additionally, the market witnessed a substantial uptick in the latter stages of the pandemic, driven by the rollout of multiple COVID-19 vaccines. For instance, in July 2022, the United States Department of Health and Human Services (HHS) secured 3.2 million doses of Novavax's COVID-19 vaccine in conjunction with the Department of Defense. This procurement highlighted the urgent need for a vast quantity of disposable syringes to inoculate a large patient population, further fueling market expansion. Overall, the pandemic underscored the critical role of disposable syringes in public health, significantly boosting the market’s growth.
Factors such as increasing activities by various NGOs to raise awareness of the use of disposable syringes, the need to control the spread of diseases like HIV, and the rising demand for disposable syringes are expected to boost the market's growth during the forecast period.
Government bodies and NGOs have implemented needle exchange programs, providing a structured approach to dispose of used syringes safely. In a notable instance, in February 2023, the Michigan Department of Health and Human Services, in collaboration with Vital Strategies and researchers from the Bloomberg School of Public Health's Bloomberg Overdose Prevention Initiative, interviewed syringe services program operators across Michigan. The aim was to identify the primary factors contributing to the state's sudden surge in service availability. These initiatives promote responsible syringe use and alleviate concerns around their disposal, consequently driving up the demand for disposable syringes in the coming years.
Additionally, the high burden of infectious diseases, such as HIV infection, which may spread through reused syringes among the population, raises the demand for disposable syringes. This, in turn, is expected to propel the market’s growth during the forecast period. For instance, as per the global HIV Statistics published by the World Health Organization, by the end of 2023, approximately 39.9 million individuals were living with HIV, whereas 1.4 million were children (aged 0–14), and the remaining 38.6 million were adults (15 years and older). Besides, according to the data published by HIV.gov in June 2023, it was observed that sharing and reusing needles, syringes, or other injection equipment may increase the risk of getting or transmitting HIV or hepatitis B and C. Hence, to prevent the spread of such deadly diseases, the utilization of disposable syringes is expected to rise, thus contributing to the market's growth.
The companies' rising focus on adopting key strategic activities, such as partnerships, agreements, and new product launches, is expected to increase the availability of disposable syringes in the market. For instance, in May 2022, Sharps Technology Inc. patented the single-use smart safety syringe products and announced that it completed the acquisition of Safeguard Medical's syringe manufacturing facility in Hungary. Such instances are expected to contribute to the market's growth.
Therefore, owing to the rising government initiatives, the higher risk of acquiring infectious diseases, and increasing company activities, the market studied is expected to grow during the forecast period. However, the comparatively high one-time cost and stringent regulatory regulations are expected to hinder the growth of the disposable syringes market during the forecast period.
Disposable Syringes Market Trends
Retractable Safety Syringes Segment Expected to Witness Significant Growth During the Forecast Period
The retractable safety syringes are used for subcutaneous, intramuscular, and intravenous injections. These syringes possess a safety mechanism that automatically retracts the needle into the plunger after the injection to protect an accidental needle stick and for secondary use.
A retractable safety syringe has a built-in safety mechanism to reduce the risk of needlestick injuries to healthcare workers and others. The needle on a safety syringe can be detachable or permanently attached. In some models, a sheath is placed over the needle; in others, the needle retracts into the barrel. For instance, as per the article published in September 2023 in the Expert Review of Medical Devices, the researchers showed that over 98% of healthcare providers held a notably high regard for the safety of the passive technology in the retractable safety syringes, especially when compared to existing products like a hinge cap active safety needle, a retractable safety needle, and a retractable safety syringe.
The consensus among the HCPs was that the passive safety feature of the needle not only had the potential to eliminate needlestick injury (NSIs) but also offered superior protection against bloodborne pathogens compared to its counterparts. In their collective opinion, this passive safety needle stood out as the safest medical device available. Thus, the advantages of such retractable safety syringes are expected to increase the segment's growth during the forecast period.
For insulin syringes, when the plunger handle is fully depressed, the syringe's needle automatically retracts into its barrel. The syringes include significantly lower dead space volume than a traditional Luer lock syringe and needle, which may result in reduced medication waste. It also provides the clinician a choice of when to activate the safety feature, before or after the needle is withdrawn from the patient. The launch of insulin syringes is one of the major factors driving the segment's growth.
For instance, in November 2023, Terumo India unveiled its Insulin Syringe, tailored for patients needing routine insulin injections, setting a new standard in patient comfort and treatment adherence. Furthermore, in February 2023, Zephyrus Innovations (Zephyrus), a private medical device company specializing in safety syringes and Closed System Transfer Devices (CSTDs), secured its inaugural product 510(k) marketing approval from the United States Food and Drug Administration (FDA) for its Aeroject 3ml safety syringe. The needle system features an internal mechanism that automatically retracts the needle into the syringe upon activation. Activation happens as the forward plunger movement pierces the propellant gas cell in the needle assembly, triggering the needle's retraction.
Hence, the advantages of retractable syringes and innovation in products and launches are expected to increase the demand for these syringes, which may fuel the market's growth in the near future.
North America Expected to Hold Significant Market Share During the Forecast Period
North America is anticipated to hold a significant market share during the forecast period owing to factors such as the high burden of various diseases leading to an increase in the need for diagnosis and treatment, the need for the prevention of infectious diseases, increasing approvals and launches of parenteral drugs. In addition, the government's initiatives to prevent bloodborne infections and the establishment of new hospitals are expected to drive the market’s growth during the forecast period.
The high burden of hospital admissions is expected to contribute to the market's growth. For instance, Canada witnessed a rise in acute inpatient hospitalizations, reaching 2.96 million in 2022–2023, compared to 2.88 million in 2022. The hospitalization rate was 7,000 per 100,000 individuals when normalized for demographic shifts. The high burden of admission in hospitals creates the need for disposable syringes for treatment and diagnosis purposes, which is expected to contribute to the market's growth.
Furthermore, the initiatives taken by the government authority to ensure proper disposal of single-use syringes and avoid multiple usages of disposable syringes are expected to augment the market growth. For instance, in April 2023, the public syringe disposal pilot program was launched in Dover by installing two-needle disposal units. This program addresses public concerns about the improper disposal of syringes in Dover, Delaware. Such initiatives create awareness about the proper use of disposable syringes, hence expected to contribute to the market’s growth.
Moreover, the rising number of new product launches is expected to increase the availability of disposable syringes in the market. For instance, in February 2023, Phillips-Medisize, a Molex company, expanded its product portfolio by introducing a disposable pen injector.
Therefore, owing to the higher risk of acquiring infectious diseases, increasing hospital admissions, growing government initiatives, and rising launches of disposable syringes, the market studied is expected to grow in the North American region during the forecast period.
Disposable Syringes Industry Overview
The disposable syringes market is fragmented in nature due to the presence of a large number of companies. The competitive landscape includes analyzing a few international and local companies with notable market shares. Some of the key companies in the market are Gerresheimer AG, Baxter International Inc., Becton, Dickinson and Company, B. Braun SE, Cardinal Health, and Terumo Corporation, among others.
Disposable Syringes Market Leaders
-
Baxter International, Inc.
-
Becton, Dickinson and Company
-
Terumo Corporation
-
B. Braun SE
-
Gerresheimer AG
*Disclaimer: Major Players sorted in no particular order
Disposable Syringes Market News
- In March 2024, BD reported an increase in the domestic production of syringes to meet the rising demands. Following the United States Food and Drug Administration (FDA) safety communication in November 2023, BD ramped up syringe manufacturing at its facilities in Nebraska and Connecticut to meet heightened customer demand.
- In March 2024, Hindustan Syringes and Medical Devices (HMD), a prominent producer of disposable and auto-disable syringes, unveiled Dispojekt, a single-use safety syringe designed to curb needle stick injuries. In the first phase, the company aimed to produce 200 million syringes and needles annually, backed by an initial investment of approximately USD 8.36 million.
Disposable Syringes Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing Activities by Various NGO's that Create Awareness for the Use of Disposable Syringes
- 4.2.2 Need to Control the Spread of Diseases like HIV
- 4.2.3 Rising Demand of Injectable Drugs
-
4.3 Market Restraints
- 4.3.1 Comparatively High One-time Cost
- 4.3.2 Stringent Government Regulations
-
4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
- 4.5 Impact of COVID-19 on the Market
5. MARKET SEGMENTATION (Market Size by Value - USD)
-
5.1 By Type
- 5.1.1 Conventional Syringes
- 5.1.2 Safety Syringes
- 5.1.2.1 Retractable Safety Syringes
- 5.1.2.2 Non-retractable Safety Syringes
-
5.2 By End Users
- 5.2.1 Hospitals
- 5.2.2 Diagnostic Laboratories
- 5.2.3 Other End Users
-
5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Gerresheimer AG
- 6.1.2 Baxter International Inc.
- 6.1.3 Becton, Dickinson and Company
- 6.1.4 B. Braun SE
- 6.1.5 Cardinal Health
- 6.1.6 Schott AG
- 6.1.7 Hindustan Syringes & Medical Devices Ltd
- 6.1.8 Nipro
- 6.1.9 Retractable Technologies Inc.
- 6.1.10 Terumo Corporation
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Disposable Syringes Market Industry Segmentation
As per the scope of this report, disposable syringes refer to single-use syringes disposed of after single use. Disposable syringes eliminate the need for sterilization as they are intended for single-use, and commercial versions come pre-sterilized.
The disposable syringes market is segmented by type, end users, and geography. By type, the market is segmented into conventional syringes and safety syringes. By safety syringes, the market is segmented into retractable safety syringes and non-retractable safety syringes. By end user, the market is segmented into hospitals, diagnostic laboratories, and other end-users. The report offers the market size in value terms in USD for all the abovementioned segments.
| By Type | Conventional Syringes | |
| Safety Syringes | Retractable Safety Syringes | |
| Non-retractable Safety Syringes | ||
| By End Users | Hospitals | |
| Diagnostic Laboratories | ||
| Other End Users | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Disposable Syringes Market Research FAQs
How big is the Disposable Syringes Market?
The Disposable Syringes Market size is expected to reach USD 15.77 billion in 2024 and grow at a CAGR of 9.53% to reach USD 24.86 billion by 2029.
What is the current Disposable Syringes Market size?
In 2024, the Disposable Syringes Market size is expected to reach USD 15.77 billion.
Who are the key players in Disposable Syringes Market?
Baxter International, Inc., Becton, Dickinson and Company, Terumo Corporation, B. Braun SE and Gerresheimer AG are the major companies operating in the Disposable Syringes Market.
Which is the fastest growing region in Disposable Syringes Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Disposable Syringes Market?
In 2024, the North America accounts for the largest market share in Disposable Syringes Market.
What years does this Disposable Syringes Market cover, and what was the market size in 2023?
In 2023, the Disposable Syringes Market size was estimated at USD 14.27 billion. The report covers the Disposable Syringes Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Disposable Syringes Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Disposable Syringe Industry Report
Statistics for the 2024 Disposable Syringe market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Disposable Syringe analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
